2017 Clinical Endocrinology Update

Chicago, IL US

Welcome to Clinical Endocrinology Update 2017!

Keep your endocrine practice up-to-date by attending Clinical Endocrinology Update (CEU). This three day meeting provides the latest information available in clinical endocrinology. Taught by expert faculty in a dynamic meeting format, you will return from CEU confident that your endocrine practice benefits from the most current and advanced information possible.

This continuing medical education activity should be of substantial interest to endocrinologists, endocrine fellows, primary care and internal medicine physicians, and health care professionals who treat and care for patients with endocrine disorders, as well as others seeking an update in recent developments in the treatment of endocrine disorders.

Seeking to claim MOC credits or get your CME certificate?

Use this form to complete the evaluation for the 2017 Clinical Endocrinology Update meeting and to claim MOC credits and a CME certificate.

After completing the evaluation form, a CME certificate will be displayed; please print or save this certificate for your records. You can log back in at any time to review your credit transcript and reprint the certificate. 

Learning Objectives

Upon completion of this educational activity, learners will be better able to:

  • Discuss state-of-the-art research in endocrinology
  • Demonstrate updated knowledge of the pathophysiology, diagnosis, and treatment of diabetes, obesity, cardiovascular disease, dyslipidemia, as well as adrenal, metabolic, bone, pediatric, pituitary, thyroid, and reproductive endocrine disorders
  • Employ enhanced skills and practice management techniques to improve patient care

Additional Information

Target Audience: 
Clinical researcher
Scientific researcher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
Systems-based Practice
Topic Area: 
Adrenal/HPA Axis
Bone and Calciotropic Hormones
Diabetes and Glucose Metabolism
Lipid Disorders and Fatty Liver Diseases
Endocrine Disruptors
Quality Improvement and Healthcare Delivery
General Endocrinology
Hormone Abuse
Growth Disorders
Health Disparities
Hormones and Cancer
Men’s Health
Neuroendocrinology and Pituitary
Pediatric Endocrinology
Thyroid/HPT Axis
Women’s Health
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Activity summary
Available credit: 
  • 22.50 ABIM MOC
  • 22.50 AMA PRA Category 1 Credits
  • 22.50 CME Certificate of Participation
Course opens: 
Course expires: 

DAY 1 – Saturday, September 23, 2017

6:45–7:45 AMRegistration/Continental Breakfast
7:45–7:55 AMWelcome and Introduction to the 69th Annual Clinical Endocrinology Update
Janet Schlechte, MD
7:55–8:25 AMPostmenopausal Osteoporosis: Role/Timing of Anabolic Therapies
Michael McClung, MD
8:25–8:55 AMThe Risk of Atypical Femur Fractures and Osteonecrosis of the Jaw
Bo Abrahamsen, MD, PhD
8:55–9:25 AMManaging a Patient Who Fractures on Osteoporosis Treatment
Robert Wermers, MD
9:25–9:55 AMHypoparathyroidism: Guidelines and New Treatments
Natalie Cusano, MD
9:55–10:10 AMPanel Discussion
10:10–10:20 AMBREAK
10:20–10:50 AMAssessment of the Obese Patient
Robert Kushner, MD
10:50–1120 AMWhat Have We Learned from the Look AHEAD Trial?
Donna Ryan, MD
11:20–11:50 AMKey Controversies in Lipidology
Ira Goldberg, MD
11:50 AM–12:05 PMPanel Discussion
12:05–1:20 PMLUNCH
1:20–2:05 PMMeet-the-Professor (MTP) Sessions
 1. Fractures in Diabetes: Risk Factors, Assessment, and Clinical Recommendations
Bo Abrahamsen, MD, PhD

2. Bones and Stones After Bariatric Surgery
Naim Maalouf, MD

3. Commercial Weight Loss Programs and Phone Apps
Donna Ryan, MD

4. Behavioral Considerations in the Evaluation and Treatment of the Patient with Obesity
Patrick O'Neil, PhD

5. Hormone Replacement Therapy
    Female (1:20–2:05 PM only): Andrea Dunaif, MD
    Male (5:30–6:15 PM only): Robert McLachlan, MD, PhD
 6. Challenging Male Hypogonadism Cases
Frances Hayes, MD
2:05–2:15 PMBREAK
2:15–2:45 PMUpdate on Female Contraception
2:45–3:15 PMPCOS Through the Lifespan
Andrea Dunaif, MD
3:15–3:45 PMGender Dysphoria/Gender Incongruence: An Update on the Endocrine Society’s New Clinical Practice Guideline
Joshua Safer, MD
3:45–4:00 PMPanel Discussion
4:00–4:10 PMBREAK
4:10–4:40 PMTreatment of Male Hypogonadism without Testosterone
Bradley Anawalt, MD
4:40–5:10 PMMale Infertility—What the Endocrinologist Needs to Know
Robert McLachlan, MD, PhD
5:10–5:25 PMPanel Discussion
5:30–6:15 PMMTP Sessions Repeat
6:15 PMAdjourn


DAY 2 – Sunday, September 24, 2017

7:15–7:45 AMContinental Breakfast
7:45–7:55 AMIntroduction
Janet Schlechte, MD
7:55–8:25 AMManagement of Diabetes in Patients with ESRD and CKD: Therapeutic Options and Considerations
David Baldwin, Jr., MD
8:25–8:55 AMPractical Approach to Diagnosing and Treating MODY
Louis Philipson, MD, PhD
8:55–9:40 AMDebate: What's Next After Metformin in Patients with Type 2 Diabetes and Cardiovascular Disease?
Carol Wysham, MD
Willy Valencia, MD, MSc
9:40–9:55 AMPanel Discussion
9:55–10:10 AMBREAK
10:10–10:40 AMPrevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology
Anders Carlson, MD
10:40–11:10 AMCombining Basal Insulin and Non-Insulin Agents in Type 2 Diabetes Treatment
Carol Wysham, MD
11:10–11:40 AMEarly Combination Therapy in Type 2 Diabetes
Janet McGill, MD
11:40–11:55 AMPanel Discussion
11:55 AM–1:10 PMLUNCH
11:55 AM–1:05 PM

Ancillary Symposium: Prandial Insulin Updates for the Diabetes Specialist*
*No registration required

1:10–1:55 PMMeet-the-Professor (MTP) Sessions
 7. Diabetes Treatment in the Elderly
Willy Valencia, MD, MSc
 8. Progress Toward Closed Loop Insulin Delivery
Steven Russell, MD, PhD
 9. Practical Management of Pregestational Diabetes in Pregnancy
Florence Brown, MD
 10. Pharmacotherapy of Obesity
Louis Aronne, MD
 11. Growth Hormone Treatment in Adults: Diagnosis and Monitoring
Shlomo Melmed, MD
 12. Management of Diabetes Insipidus (1:10–1:55 PM only)
      Management of SIADH (4:35–5:20 PM only)

Joseph Verbalis, MD
1:55–2:05 PMBREAK
2:05–2:50 PMControversies in the Diagnosis and Management of Acromegaly
Shlomo Melmed, MD
Laurence Katznelson, MD
Mark Molitch, MD
2:50–3:20 PMProlactinomas are Sometimes Harder to Treat
Mark Molitch, MD
3:20–4:05 PMControversies in the Diagnosis and Management of Cushing Syndrome
Lynnette Nieman, MD
Laurence Katznelson, MD
James Findling, MD
4:05–4:20 PMPanel Discussion
4:20–4:35 PMBREAK
4:35–5:20 PMMTP Sessions Repeat
5:20 PMAdjourn


DAY 3 – Monday, September 25, 2017

7:15–7:45 AMContinental Breakfast
7:45–7:55 AMIntroduction
Janet Schlechte, MD
7:55–8:25 AMWhat's New in Primary Aldosteronism?
William F. Young, Jr., MD, MSc
8:25–8:55 AMAdrenal Fatigue Is Not Adrenal Insufficiency
Lynnette Nieman, MD
8:55–9:25 AMNeuroendocrine Imaging
Richard Auchus, MD, PhD
9:25–9:40 AMPanel Discussion
9:55–10:40 AMMeet-the-Professor (MTP) Sessions
 13. Glucocorticoid Replacement Therapy
James Findling, MD
 14. Endocrine Hypertension
William F. Young, Jr., MD, MSc
 15. Thyroid Nodules: Diagnosis and Management
Susan Mandel, MD, MPH
 16. Thyrotoxicosis: Different Treatment Options
David Cooper, MD
10:50–11:20 AMMolecular Markers for Thyroid Nodules and Cancer: Implications on Surgical Management and Follow-Up
Electron Kebebew, MD
11:20–11:50 AMSubclinical Thyroid Disorders: Indications for Treatment
Anne Cappola, MD, ScM
11:50 AM–12:05 PMPanel Discussion
1:20–2:05 PMMTP Sessions Repeat
2:10–2:40 PMThyroid Disorders During Pregnancy
Susan Mandel, MD, MPH
2:40–3:10 PMCombination T4/T3 Therapy in Hypothyroidism
Douglas Ross, MD
3:10–3:25 PMPanel Discussion
3:25–3:30 PMClosing and Adjournment
Janet Schlechte, MD
Chicago Marriott Downtown Magnificent Mile
540 N. Michigan Avenue
Grand Ballroom, Level 7
Chicago, IL 60611
United States

Disclosure Policy

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to The Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. 

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

To view disclosure information for all CEU presenters, please view the full schedule. Within each session description a link to speaker disclosure is presented.


The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.


The educational content in this self-assessment test relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.


When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.


The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.


The Endocrine Society is proud to partner with industry to advance excellence and promote scientific discovery, medical practice and human health.:

Click "Start" to complete meeting evaluation, claim CME & Maintenance of Certification (MOC) points, and print a certificate of attendance or certificate of participation

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.The Endocrine Society designates this live activity for a maximum of 22.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC):

By attending CEU2017, you are eligible to earn a maximum of 22.5 American Board of Internal Medicine (ABIM) Medical Knowledge MOC points.

In order to earn and report MOC points to the American Board of Internal Medicine (ABIM), you must:

  1. Provide your board-certification information in your educational profile

Review & Edit your Profile

Available Credit

  • 22.50 ABIM MOC
  • 22.50 AMA PRA Category 1 Credits
  • 22.50 CME Certificate of Participation

Accreditation Period

Course opens: 
Course expires: 

Login to your Endocrine Society account and click the blue Start button to begin your evaluation.